In other studies, hypoalbuminemia, defined as either an albumin < 3.0 or <3.5 mg/dL, was used as a component of perioperative predictive scoring models that assess frailty and fitness to predict outcomes for pancreatic cancer and pancreatic surgery [23,24,25]. Here, ALB is linked to familial pancreatic carcinoma.